Growth Metrics

Idexx Laboratories (IDXX) Accounts Payables (2016 - 2025)

Idexx Laboratories has reported Accounts Payables over the past 17 years, most recently at $110.4 million for Q4 2025.

  • Quarterly results put Accounts Payables at $110.4 million for Q4 2025, down 3.33% from a year ago — trailing twelve months through Dec 2025 was $110.4 million (down 3.33% YoY), and the annual figure for FY2025 was $110.4 million, down 3.33%.
  • Accounts Payables for Q4 2025 was $110.4 million at Idexx Laboratories, down from $122.3 million in the prior quarter.
  • Over the last five years, Accounts Payables for IDXX hit a ceiling of $127.3 million in Q2 2022 and a floor of $86.7 million in Q3 2021.
  • Median Accounts Payables over the past 5 years was $113.4 million (2023), compared with a mean of $111.5 million.
  • Biggest five-year swings in Accounts Payables: surged 55.77% in 2021 and later decreased 15.4% in 2023.
  • Idexx Laboratories' Accounts Payables stood at $116.1 million in 2021, then fell by 5.1% to $110.2 million in 2022, then rose by 0.38% to $110.6 million in 2023, then grew by 3.22% to $114.2 million in 2024, then dropped by 3.33% to $110.4 million in 2025.
  • The last three reported values for Accounts Payables were $110.4 million (Q4 2025), $122.3 million (Q3 2025), and $116.6 million (Q2 2025) per Business Quant data.